1 Study Coverage 1.1 Genome-Based Drug Product Introduction 1.2 Market by Type 1.2.1 Global Genome-Based Drug Market Size Growth Rate by Type 1.2.2 Insulin 1.2.3 Growth Hormone 1.2.4 Monoclonal Antibody 1.2.5 Other 1.3 Market by Application 1.3.1 Global Genome-Based Drug Market Size Growth Rate by Application 1.3.2 Hospital 1.3.3 Pharmaceutical Factory 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Genome-Based Drug Market Size, Estimates and Forecasts 2.1.1 Global Genome-Based Drug Revenue 2016-2027 2.1.2 Global Genome-Based Drug Sales 2016-2027 2.2 Global Genome-Based Drug, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Genome-Based Drug Historical Market Size by Region (2016-2021) 2.3.1 Global Genome-Based Drug Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Genome-Based Drug Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Genome-Based Drug Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Genome-Based Drug Sales Forecast by Region (2022-2027) 2.4.2 Global Genome-Based Drug Revenue Forecast by Region (2022-2027) 3 Global Genome-Based Drug Competitor Landscape by Players 3.1 Global Top Genome-Based Drug Manufacturers by Sales 3.1.1 Global Genome-Based Drug Sales by Manufacturer (2016-2021) 3.1.2 Global Genome-Based Drug Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Genome-Based Drug Manufacturers by Revenue 3.2.1 Key Genome-Based Drug Manufacturers Covered: Ranking by Revenue 3.2.2 Global Genome-Based Drug Revenue by Manufacturers (2016-2021) 3.2.3 Global Genome-Based Drug Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Genome-Based Drug Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Genome-Based Drug Revenue in 2020 3.2.6 Global Genome-Based Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Genome-Based Drug Price by Manufacturers 3.4 Global Genome-Based Drug Manufacturing Base Distribution, Product Types 3.4.1 Genome-Based Drug Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Genome-Based Drug Product Type 3.4.3 Date of International Manufacturers Enter into Genome-Based Drug Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Genome-Based Drug Market Size by Type (2016-2021) 4.1.1 Global Genome-Based Drug Sales by Type (2016-2021) 4.1.2 Global Genome-Based Drug Revenue by Type (2016-2021) 4.1.3 Genome-Based Drug Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Genome-Based Drug Market Size Forecast by Type (2022-2027) 4.2.1 Global Genome-Based Drug Sales Forecast by Type (2022-2027) 4.2.2 Global Genome-Based Drug Revenue Forecast by Type (2022-2027) 4.2.3 Genome-Based Drug Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Genome-Based Drug Market Size by Application (2016-2021) 5.1.1 Global Genome-Based Drug Sales by Application (2016-2021) 5.1.2 Global Genome-Based Drug Revenue by Application (2016-2021) 5.1.3 Genome-Based Drug Price by Application (2016-2021) 5.2 Genome-Based Drug Market Size Forecast by Application (2022-2027) 5.2.1 Global Genome-Based Drug Sales Forecast by Application (2022-2027) 5.2.2 Global Genome-Based Drug Revenue Forecast by Application (2022-2027) 5.2.3 Global Genome-Based Drug Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Genome-Based Drug Market Size YoY Growth 2016-2027 6.1.1 Japan Genome-Based Drug Sales YoY Growth 2016-2027 6.1.2 Japan Genome-Based Drug Revenue YoY Growth 2016-2027 6.1.3 Japan Genome-Based Drug Market Share in Global Market 2016-2027 6.2 Japan Genome-Based Drug Market Size by Players (International and Local Players) 6.2.1 Japan Top Genome-Based Drug Players by Sales (2016-2021) 6.2.2 Japan Top Genome-Based Drug Players by Revenue (2016-2021) 6.3 Japan Genome-Based Drug Historic Market Review by Type (2016-2021) 6.3.1 Japan Genome-Based Drug Sales Market Share by Type (2016-2021) 6.3.2 Japan Genome-Based Drug Revenue Market Share by Type (2016-2021) 6.3.3 Japan Genome-Based Drug Price by Type (2016-2021) 6.4 Japan Genome-Based Drug Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Genome-Based Drug Sales Forecast by Type (2022-2027) 6.4.2 Japan Genome-Based Drug Revenue Forecast by Type (2022-2027) 6.4.3 Japan Genome-Based Drug Price Forecast by Type (2022-2027) 6.5 Japan Genome-Based Drug Historic Market Review by Application (2016-2021) 6.5.1 Japan Genome-Based Drug Sales Market Share by Application (2016-2021) 6.5.2 Japan Genome-Based Drug Revenue Market Share by Application (2016-2021) 6.5.3 Japan Genome-Based Drug Price by Application (2016-2021) 6.6 Japan Genome-Based Drug Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Genome-Based Drug Sales Forecast by Application (2022-2027) 6.6.2 Japan Genome-Based Drug Revenue Forecast by Application (2022-2027) 6.6.3 Japan Genome-Based Drug Price Forecast by Application (2022-2027) 7 North America 7.1 North America Genome-Based Drug Market Size YoY Growth 2016-2027 7.2 North America Genome-Based Drug Market Facts & Figures by Country 7.2.1 North America Genome-Based Drug Sales by Country (2016-2021) 7.2.2 North America Genome-Based Drug Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Genome-Based Drug Market Size YoY Growth 2016-2027 8.2 Asia Pacific Genome-Based Drug Market Facts & Figures by Region 8.2.1 Asia Pacific Genome-Based Drug Sales by Region (2016-2021) 8.2.2 Asia Pacific Genome-Based Drug Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Genome-Based Drug Market Size YoY Growth 2016-2027 9.2 Europe Genome-Based Drug Market Facts & Figures by Country 9.2.1 Europe Genome-Based Drug Sales by Country (2016-2021) 9.2.2 Europe Genome-Based Drug Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Genome-Based Drug Market Size YoY Growth 2016-2027 10.2 Latin America Genome-Based Drug Market Facts & Figures by Country 10.2.1 Latin America Genome-Based Drug Sales by Country (2016-2021) 10.2.2 Latin America Genome-Based Drug Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Genome-Based Drug Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Genome-Based Drug Market Facts & Figures by Country 11.2.1 Middle East and Africa Genome-Based Drug Sales by Country (2016-2021) 11.2.2 Middle East and Africa Genome-Based Drug Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Sandoz International 12.1.1 Sandoz International Corporation Information 12.1.2 Sandoz International Description and Business Overview 12.1.3 Sandoz International Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Sandoz International Genome-Based Drug Products Offered 12.1.5 Sandoz International Recent Development 12.2 Teva pharmaceutical industries 12.2.1 Teva pharmaceutical industries Corporation Information 12.2.2 Teva pharmaceutical industries Description and Business Overview 12.2.3 Teva pharmaceutical industries Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Teva pharmaceutical industries Genome-Based Drug Products Offered 12.2.5 Teva pharmaceutical industries Recent Development 12.3 Mylan 12.3.1 Mylan Corporation Information 12.3.2 Mylan Description and Business Overview 12.3.3 Mylan Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Mylan Genome-Based Drug Products Offered 12.3.5 Mylan Recent Development 12.4 3SBio 12.4.1 3SBio Corporation Information 12.4.2 3SBio Description and Business Overview 12.4.3 3SBio Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021) 12.4.4 3SBio Genome-Based Drug Products Offered 12.4.5 3SBio Recent Development 12.5 Shanghai Fosun Pharmaceutical 12.5.1 Shanghai Fosun Pharmaceutical Corporation Information 12.5.2 Shanghai Fosun Pharmaceutical Description and Business Overview 12.5.3 Shanghai Fosun Pharmaceutical Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Shanghai Fosun Pharmaceutical Genome-Based Drug Products Offered 12.5.5 Shanghai Fosun Pharmaceutical Recent Development 12.6 Tonghua Dongbao Pharmaceutical 12.6.1 Tonghua Dongbao Pharmaceutical Corporation Information 12.6.2 Tonghua Dongbao Pharmaceutical Description and Business Overview 12.6.3 Tonghua Dongbao Pharmaceutical Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Tonghua Dongbao Pharmaceutical Genome-Based Drug Products Offered 12.6.5 Tonghua Dongbao Pharmaceutical Recent Development 12.7 Biocon 12.7.1 Biocon Corporation Information 12.7.2 Biocon Description and Business Overview 12.7.3 Biocon Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Biocon Genome-Based Drug Products Offered 12.7.5 Biocon Recent Development 12.8 Reliance Life Sciences 12.8.1 Reliance Life Sciences Corporation Information 12.8.2 Reliance Life Sciences Description and Business Overview 12.8.3 Reliance Life Sciences Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Reliance Life Sciences Genome-Based Drug Products Offered 12.8.5 Reliance Life Sciences Recent Development 12.9 Probiomed 12.9.1 Probiomed Corporation Information 12.9.2 Probiomed Description and Business Overview 12.9.3 Probiomed Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Probiomed Genome-Based Drug Products Offered 12.9.5 Probiomed Recent Development 12.10 Biosidus 12.10.1 Biosidus Corporation Information 12.10.2 Biosidus Description and Business Overview 12.10.3 Biosidus Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Biosidus Genome-Based Drug Products Offered 12.10.5 Biosidus Recent Development 12.11 Sandoz International 12.11.1 Sandoz International Corporation Information 12.11.2 Sandoz International Description and Business Overview 12.11.3 Sandoz International Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Sandoz International Genome-Based Drug Products Offered 12.11.5 Sandoz International Recent Development 12.12 Celltrion 12.12.1 Celltrion Corporation Information 12.12.2 Celltrion Description and Business Overview 12.12.3 Celltrion Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Celltrion Products Offered 12.12.5 Celltrion Recent Development 12.13 LG Life Science 12.13.1 LG Life Science Corporation Information 12.13.2 LG Life Science Description and Business Overview 12.13.3 LG Life Science Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021) 12.13.4 LG Life Science Products Offered 12.13.5 LG Life Science Recent Development 12.14 Dong-A Pharmaceutical 12.14.1 Dong-A Pharmaceutical Corporation Information 12.14.2 Dong-A Pharmaceutical Description and Business Overview 12.14.3 Dong-A Pharmaceutical Genome-Based Drug Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Dong-A Pharmaceutical Products Offered 12.14.5 Dong-A Pharmaceutical Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Genome-Based Drug Industry Trends 13.2 Genome-Based Drug Market Drivers 13.3 Genome-Based Drug Market Challenges 13.4 Genome-Based Drug Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Genome-Based Drug Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Genome-Based Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Insulin Table 3. Major Manufacturers of Growth Hormone Table 4. Major Manufacturers of Monoclonal Antibody Table 5. Major Manufacturers of Other Table 6. Global Genome-Based Drug Market Size Growth Rate by Application (2021-2027) & (Kiloton) Table 7. Global Genome-Based Drug Market Size by Region (Kiloton) & (US$ Million), 2016 VS 2021 VS 2027 Table 8. Global Genome-Based Drug Sales by Regions (2016-2021) & (Kiloton) Table 9. Global Genome-Based Drug Sales Market Share by Regions (2016-2021) Table 10. Global Genome-Based Drug Revenue by Regions (2016-2021) & (US$ Million) Table 11. Global Genome-Based Drug Sales Forecast by Region (2022-2027) & (Kiloton) Table 12. Global Genome-Based Drug Sales Market Share Forecast by Region (2022-2027) Table 13. Global Genome-Based Drug Revenue Forecast by Region (2022-2027) & (US$ Million) Table 14. Global Genome-Based Drug Revenue Market Share Forecast by Region (2022-2027) Table 15. Global Genome-Based Drug Sales by Manufacturers (2016-2021) (Kiloton) Table 16. Global Genome-Based Drug Sales Share by Manufacturers (2016-2021) Table 17. Ranking of Global Top Genome-Based Drug Manufacturers by Revenue (US$ Million) in 2020 Table 18. Genome-Based Drug Revenue by Manufacturers (2016-2021) (US$ Million) Table 19. Genome-Based Drug Revenue Share by Manufacturers (2016-2021) Table 20. Global Genome-Based Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 21. Global Genome-Based Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genome-Based Drug as of 2020) Table 22. Key Manufacturers Genome-Based Drug Price (2016-2021) (US$/Ton) Table 23. Genome-Based Drug Manufacturers Manufacturing Base Distribution and Headquarters Table 24. Manufacturers Genome-Based Drug Product Type Table 25. Date of International Manufacturers Enter into Genome-Based Drug Market Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans Table 27. Global Genome-Based Drug Sales by Type (2016-2021) (Kiloton) Table 28. Global Genome-Based Drug Sales Share by Type (2016-2021) Table 29. Global Genome-Based Drug Revenue by Type (2016-2021) (US$ Million) Table 30. Global Genome-Based Drug Revenue Share by Type (2016-2021) Table 31. Genome-Based Drug Average Selling Price (ASP) by Type (2016-2021) & (US$/Ton) Table 32. Global Genome-Based Drug Sales Forecast by Type (2022-2027) & (Kiloton) Table 33. Global Genome-Based Drug Sales Market Share Forecast by Type (2022-2027) Table 34. Global Genome-Based Drug Revenue Forecast V (2022-2027) & (US$ Million) Table 35. Global Genome-Based Drug Revenue Market Share Forecast by Type (2022-2027) Table 36. Global Genome-Based Drug Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Ton) Table 37. Global Genome-Based Drug Sales by Application (2016-2021) (Kiloton) Table 38. Global Genome-Based Drug Sales Share by Application (2016-2021) Table 39. Global Genome-Based Drug Revenue by Application (2016-2021) (US$ Million) Table 40. Global Genome-Based Drug Revenue Share by Application (2016-2021) Table 41. Genome-Based Drug Average Selling Price (ASP) by Application (2016-2021) & (US$/Ton) Table 42. Global Genome-Based Drug Sales Forecast by Application (2022-2027) & (Kiloton) Table 43. Global Genome-Based Drug Sales Market Share Forecast by Application (2022-2027) Table 44. Global Genome-Based Drug Revenue Forecast by Application (2022-2027) & (US$ Million) Table 45. Global Genome-Based Drug Revenue Market Share Forecast by Application (2022-2027) Table 46. Global Genome-Based Drug Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Ton) Table 47. Japan Genome-Based Drug Sales (Kiloton) of Key Companies (2016-2021) Table 48. Japan Genome-Based Drug Sales Share by Company (2016-2021) Table 49. Japan Genome-Based Drug Revenue (US$ Million) by Company (2016-2021) Table 50. Japan Genome-Based Drug Revenue Share by Company (2016-2021) Table 51. Japan Genome-Based Drug Sales (Kiloton) by Type (2016-2021) Table 52. Japan Genome-Based Drug Sales Share by Type (2016-2021) Table 53. Japan Genome-Based Drug Revenue (US$ Million) Market Share by Type (2016-2021) Table 54. Japan Genome-Based Drug Price (US$/Ton) by Type (2016-2021) Table 55. Japan Genome-Based Drug Sales (Kiloton) by Type (2022-2027) Table 56. Japan Genome-Based Drug Sales Share by Type (2022-2027) Table 57. Japan Genome-Based Drug Revenue (US$ Million) Market Share by Type (2022-2027) Table 58. Japan Genome-Based Drug Revenue Share by Type (2022-2027) Table 59. Japan Genome-Based Drug Price (US$/Ton) by Type (2022-2027) Table 60. Japan Genome-Based Drug Sales (Kiloton) by Application (2016-2021) Table 61. Japan Genome-Based Drug Sales Share by Application (2016-2021) Table 62. Japan Genome-Based Drug Revenue (US$ Million) Market Share by Application (2016-2021) Table 63. Japan Genome-Based Drug Price (US$/Ton) by Application (2016-2021) Table 64. Japan Genome-Based Drug Sales (Kiloton) by Application (2022-2027) Table 65. Japan Genome-Based Drug Sales Share by Application (2022-2027) Table 66. Japan Genome-Based Drug Revenue (US$ Million) Market Share by Application (2022-2027) Table 67. Japan Genome-Based Drug Revenue Share by Application (2022-2027) Table 68. Japan Genome-Based Drug Price (US$/Ton) by Application (2022-2027) Table 69. North America Genome-Based Drug Sales by Country (2016-2021) & (Kiloton) Table 70. North America Genome-Based Drug Sales Market Share by Country (2016-2021) Table 71. North America Genome-Based Drug Revenue by Country (2016-2021) & (US$ Million) Table 72. North America Genome-Based Drug Revenue Market Share by Country (2016-2021) Table 73. Asia Pacific Genome-Based Drug Sales by Region (2016-2021) & (Kiloton) Table 74. Asia Pacific Genome-Based Drug Sales Market Share by Region (2016-2021) Table 75. Asia Pacific Genome-Based Drug Revenue by Region (2016-2021) & (US$ Million) Table 76. Asia Pacific Genome-Based Drug Revenue Market Share by Region (2016-2021) Table 77. Europe Genome-Based Drug Sales by Country (2016-2021) & (Kiloton) Table 78. Europe Genome-Based Drug Sales Market Share by Country (2016-2021) Table 79. Europe Genome-Based Drug Revenue by Country (2016-2021) & (US$ Million) Table 80. Europe Genome-Based Drug Revenue Market Share by Country (2016-2021) Table 81. Latin America Genome-Based Drug Sales by Country (2016-2021) & (Kiloton) Table 82. Latin America Genome-Based Drug Sales Market Share by Country (2016-2021) Table 83. Latin Americaa Genome-Based Drug Revenue by Country (2016-2021) & (US$ Million) Table 84. Latin America Genome-Based Drug Revenue Market Share by Country (2016-2021) Table 85. Middle East and Africa Genome-Based Drug Sales by Country (2016-2021) & (Kiloton) Table 86. Middle East and Africa Genome-Based Drug Sales Market Share by Country (2016-2021) Table 87. Middle East and Africa Genome-Based Drug Revenue by Country (2016-2021) & (US$ Million) Table 88. Middle East and Africa Genome-Based Drug Revenue Market Share by Country (2016-2021) Table 89. Sandoz International Corporation Information Table 90. Sandoz International Description and Business Overview Table 91. Sandoz International Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 92. Sandoz International Genome-Based Drug Product Table 93. Sandoz International Recent Development Table 94. Teva pharmaceutical industries Corporation Information Table 95. Teva pharmaceutical industries Description and Business Overview Table 96. Teva pharmaceutical industries Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 97. Teva pharmaceutical industries Product Table 98. Teva pharmaceutical industries Recent Development Table 99. Mylan Corporation Information Table 100. Mylan Description and Business Overview Table 101. Mylan Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 102. Mylan Product Table 103. Mylan Recent Development Table 104. 3SBio Corporation Information Table 105. 3SBio Description and Business Overview Table 106. 3SBio Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 107. 3SBio Product Table 108. 3SBio Recent Development Table 109. Shanghai Fosun Pharmaceutical Corporation Information Table 110. Shanghai Fosun Pharmaceutical Description and Business Overview Table 111. Shanghai Fosun Pharmaceutical Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 112. Shanghai Fosun Pharmaceutical Product Table 113. Shanghai Fosun Pharmaceutical Recent Development Table 114. Tonghua Dongbao Pharmaceutical Corporation Information Table 115. Tonghua Dongbao Pharmaceutical Description and Business Overview Table 116. Tonghua Dongbao Pharmaceutical Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 117. Tonghua Dongbao Pharmaceutical Product Table 118. Tonghua Dongbao Pharmaceutical Recent Development Table 119. Biocon Corporation Information Table 120. Biocon Description and Business Overview Table 121. Biocon Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 122. Biocon Product Table 123. Biocon Recent Development Table 124. Reliance Life Sciences Corporation Information Table 125. Reliance Life Sciences Description and Business Overview Table 126. Reliance Life Sciences Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 127. Reliance Life Sciences Product Table 128. Reliance Life Sciences Recent Development Table 129. Probiomed Corporation Information Table 130. Probiomed Description and Business Overview Table 131. Probiomed Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 132. Probiomed Product Table 133. Probiomed Recent Development Table 134. Biosidus Corporation Information Table 135. Biosidus Description and Business Overview Table 136. Biosidus Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 137. Biosidus Product Table 138. Biosidus Recent Development Table 139. AMEGA Biotech Corporation Information Table 140. AMEGA Biotech Description and Business Overview Table 141. AMEGA Biotech Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 142. AMEGA Biotech Product Table 143. AMEGA Biotech Recent Development Table 144. Celltrion Corporation Information Table 145. Celltrion Description and Business Overview Table 146. Celltrion Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 147. Celltrion Product Table 148. Celltrion Recent Development Table 149. LG Life Science Corporation Information Table 150. LG Life Science Description and Business Overview Table 151. LG Life Science Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 152. LG Life Science Product Table 153. LG Life Science Recent Development Table 154. Dong-A Pharmaceutical Corporation Information Table 155. Dong-A Pharmaceutical Description and Business Overview Table 156. Dong-A Pharmaceutical Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 157. Dong-A Pharmaceutical Product Table 158. Dong-A Pharmaceutical Recent Development Table 159. Genome-Based Drug Market Trends Table 160. Genome-Based Drug Market Drivers Table 161. Genome-Based Drug Market Challenges Table 162. Genome-Based Drug Market Restraints Table 163. Genome-Based Drug Customers List Table 164. Genome-Based Drug Distributors List Table 165. Research Programs/Design for This Report Table 166. Key Data Information from Secondary Sources Table 167. Key Data Information from Primary Sources List of Figures Figure 1. Genome-Based Drug Product Picture Figure 2. Global Genome-Based Drug Sales Market Share by Type in 2020 & 2027 Figure 3. Insulin Product Picture Figure 4. Growth Hormone Product Picture Figure 5. Monoclonal Antibody Product Picture Figure 6. Other Product Picture Figure 7. Global Genome-Based Drug Sales Market Share by Application in 2020 & 2027 Figure 8. Hospital Figure 9. Pharmaceutical Factory Figure 10. Other Figure 11. Genome-Based Drug Report Years Considered Figure 12. Global Genome-Based Drug Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Genome-Based Drug Market Size 2016-2027 (US$ Million) Figure 14. Global Genome-Based Drug Sales 2016-2027 (Kiloton) Figure 15. Global Genome-Based Drug Market Size Market Share by Region: 2021 Versus 2027 Figure 16. Global Genome-Based Drug Sales Market Share by Region (2016-2021) Figure 17. Global Genome-Based Drug Sales Market Share by Region in 2020 Figure 18. Global Genome-Based Drug Revenue Market Share by Region (2016-2021) Figure 19. Global Genome-Based Drug Revenue Market Share by Region in 2020 Figure 20. Global Genome-Based Drug Sales Share by Manufacturer in 2020 Figure 21. The Top 10 and 5 Players Market Share by Genome-Based Drug Revenue in 2020 Figure 22. Genome-Based Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 23. Global Genome-Based Drug Sales Market Share by Type (2016-2021) Figure 24. Global Genome-Based Drug Sales Market Share by Type in 2020 Figure 25. Global Genome-Based Drug Revenue Market Share by Type (2016-2021) Figure 26. Global Genome-Based Drug Revenue Market Share by Type in 2020 Figure 27. Global Genome-Based Drug Sales Market Share by Application (2016-2021) Figure 28. Global Genome-Based Drug Sales Market Share by Application in 2020 Figure 29. Global Genome-Based Drug Revenue Market Share by Application (2016-2021) Figure 30. Global Genome-Based Drug Revenue Market Share by Application in 2020 Figure 31. Japan Genome-Based Drug Sales Growth Rate 2016-2027 (Kiloton) Figure 32. Japan Genome-Based Drug Revenue Growth Rate 2016-2027 (US$ Million) Figure 33. Japan Genome-Based Drug Market Share in Global Market 2016-2027 Figure 34. Japan 5 and 10 Largest Genome-Based Drug Players Market Share by Revenue in Genome-Based Drug in 2020 Figure 35. Japan Genome-Based Drug Revenue Share by Type (2016-2021) Figure 36. Japan Genome-Based Drug Revenue Growth Rate by Type in 2016 & 2020 Figure 37. Japan Genome-Based Drug Revenue Share by Application (2016-2021) Figure 38. Japan Genome-Based Drug Revenue Growth Rate by Application in 2016 & 2020 Figure 39. North America Genome-Based Drug Sales Growth Rate 2016-2021 (Kiloton) Figure 40. North America Genome-Based Drug Revenue Growth Rate 2016-2021 (US$ Million) Figure 41. North America Genome-Based Drug Sales Market Share by Country in 2020 Figure 42. North America Genome-Based Drug Revenue Market Share by Country in 2020 Figure 43. U.S. Genome-Based Drug Sales Growth Rate (2016-2021) (Kiloton) Figure 44. U.S. Genome-Based Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Canada Genome-Based Drug Sales Growth Rate (2016-2021) (Kiloton) Figure 46. Canada Genome-Based Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Europe Genome-Based Drug Sales Growth Rate 2016-2021 (Kiloton) Figure 48. Europe Genome-Based Drug Revenue Growth Rate 2016-2021 (US$ Million) Figure 49. Europe Genome-Based Drug Sales Market Share by Country in 2020 Figure 50. Europe Genome-Based Drug Revenue Market Share by Country in 2020 Figure 51. Germany Genome-Based Drug Sales Growth Rate (2016-2021) (Kiloton) Figure 52. Germany Genome-Based Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. France Genome-Based Drug Sales Growth Rate (2016-2021) (Kiloton) Figure 54. France Genome-Based Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. U.K. Genome-Based Drug Sales Growth Rate (2016-2021) (Kiloton) Figure 56. U.K. Genome-Based Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Italy Genome-Based Drug Sales Growth Rate (2016-2021) (Kiloton) Figure 58. Italy Genome-Based Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Russia Genome-Based Drug Sales Growth Rate (2016-2021) (Kiloton) Figure 60. Russia Genome-Based Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 61. Asia Pacific Genome-Based Drug Sales Growth Rate 2016-2021 (Kiloton) Figure 62. Asia Pacific Genome-Based Drug Revenue Growth Rate 2016-2021 (US$ Million) Figure 63. Asia Pacific Genome-Based Drug Sales Market Share by Region in 2020 Figure 64. Asia Pacific Genome-Based Drug Revenue Market Share by Region in 2020 Figure 65. China Genome-Based Drug Sales Growth Rate (2016-2021) (Kiloton) Figure 66. China Genome-Based Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. Japan Genome-Based Drug Sales Growth Rate (2016-2021) (Kiloton) Figure 68. Japan Genome-Based Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. South Korea Genome-Based Drug Sales Growth Rate (2016-2021) (Kiloton) Figure 70. South Korea Genome-Based Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. India Genome-Based Drug Sales Growth Rate (2016-2021) (Kiloton) Figure 72. India Genome-Based Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Australia Genome-Based Drug Sales Growth Rate (2016-2021) (Kiloton) Figure 74. Australia Genome-Based Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Taiwan Genome-Based Drug Sales Growth Rate (2016-2021) (Kiloton) Figure 76. Taiwan Genome-Based Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Indonesia Genome-Based Drug Sales Growth Rate (2016-2021) (Kiloton) Figure 78. Indonesia Genome-Based Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Thailand Genome-Based Drug Sales Growth Rate (2016-2021) (Kiloton) Figure 80. Thailand Genome-Based Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Malaysia Genome-Based Drug Sales Growth Rate (2016-2021) (Kiloton) Figure 82. Malaysia Genome-Based Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Philippines Genome-Based Drug Sales Growth Rate (2016-2021) (Kiloton) Figure 84. Philippines Genome-Based Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Vietnam Genome-Based Drug Sales Growth Rate (2016-2021) (Kiloton) Figure 86. Vietnam Genome-Based Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 87. Latin America Genome-Based Drug Sales Growth Rate 2016-2021 (Kiloton) Figure 88. Latin America Genome-Based Drug Revenue Growth Rate 2016-2021 (US$ Million) Figure 89. Latin America Genome-Based Drug Sales Market Share by Country in 2020 Figure 90. Latin America Genome-Based Drug Revenue Market Share by Country in 2020 Figure 91. Mexico Genome-Based Drug Sales Growth Rate (2016-2021) (Kiloton) Figure 92. Mexico Genome-Based Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Brazil Genome-Based Drug Sales Growth Rate (2016-2021) (Kiloton) Figure 94. Brazil Genome-Based Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Argentina Genome-Based Drug Sales Growth Rate (2016-2021) (Kiloton) Figure 96. Argentina Genome-Based Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 97. Middle East and Africa Genome-Based Drug Sales Growth Rate 2016-2021 (Kiloton) Figure 98. Middle East and Africa Genome-Based Drug Revenue Growth Rate 2016-2021 (US$ Million) Figure 99. Middle East and Africa Genome-Based Drug Sales Market Share by Country in 2020 Figure 100. Middle East and Africa Genome-Based Drug Revenue Market Share by Country in 2020 Figure 101. Turkey Genome-Based Drug Sales Growth Rate (2016-2021) (Kiloton) Figure 102. Turkey Genome-Based Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. Saudi Arabia Genome-Based Drug Sales Growth Rate (2016-2021) (Kiloton) Figure 104. Saudi Arabia Genome-Based Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. UAE Genome-Based Drug Sales Growth Rate (2016-2021) (Kiloton) Figure 106. UAE Genome-Based Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 107. Genome-Based Drug Value Chain Figure 108. Channels of Distribution Figure 109. Distributors Profiles Figure 110. Bottom-up and Top-down Approaches for This Report Figure 111. Data Triangulation Figure 112. Key Executives Interviewed

Sandoz International Teva pharmaceutical industries Mylan 3SBio Shanghai Fosun Pharmaceutical Tonghua Dongbao Pharmaceutical Biocon Reliance Life Sciences Probiomed Biosidus AMEGA Biotech Celltrion LG Life Science Dong-A Pharmaceutical